Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brooks Jackson

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Plos One|June 6, 2013
The good, the bad, and the unknown: quality of clinical laboratories in Kampala, UgandaAli M Elbireer, J Brooks Jackson, Hakim Sendagire, et al.
Women'S Health (London, England)|April 28, 2026
Cesarean section rates in Lucas do Rio Verde, Brazil: Assessing the impact of socioeconomic status and maternal and neonatal outcomesRamya Vemulapalli, Roni Arienti, Linder Wendt, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 27, 2026
ABO Incongruency Increases Risk for Necrotizing Enterocolitis in Preterm NeonatesJeremy A Sandgren, Numra A Aleem, J Brooks Jackson, et al.
Women'S Health Reports (New Rochelle, N.Y.)|July 22, 2024
Predictors of Postpartum Hemorrhage and Associated Outcomes at a Midwest Academic Medical CenterMegan Mooberry, Natalie Voss, Linder Wendt, et al.
AIDS Research and Human Retroviruses|October 25, 2002
Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assaysSheila M Keating, Robert C Bollinger, Thomas C Quinn, et al.
Journal of Cutaneous Pathology|June 20, 2007
Langerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infectionJanis M Taube, Andrew D Nichols, Lynette S Bornman, et al.
Journal of Clinical Microbiology|June 9, 2004
Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral loadJ Brooks Jackson, Estelle Piwowar-Manning, LeTanya Johnson-Lewis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012Susan H Eshleman, Laura A Guay, Anthony Mwatha, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|January 17, 2024
Tolerance for Ambiguity: Correlations With Medical and Physical Therapy Student Traits and Experiences Within the Learning EnvironmentShauna Dudley-Javoroski, Christopher S Cooper, J Brooks Jackson, et al.
AIDS (London, England)|February 25, 2003
A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high riskJ Brooks Jackson, Scott Barnett, Estelle Piwowar-Manning, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Plos One|June 6, 2013
The good, the bad, and the unknown: quality of clinical laboratories in Kampala, UgandaAli M Elbireer, J Brooks Jackson, Hakim Sendagire, et al.
Women'S Health (London, England)|April 28, 2026
Cesarean section rates in Lucas do Rio Verde, Brazil: Assessing the impact of socioeconomic status and maternal and neonatal outcomesRamya Vemulapalli, Roni Arienti, Linder Wendt, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 27, 2026
ABO Incongruency Increases Risk for Necrotizing Enterocolitis in Preterm NeonatesJeremy A Sandgren, Numra A Aleem, J Brooks Jackson, et al.
Women'S Health Reports (New Rochelle, N.Y.)|July 22, 2024
Predictors of Postpartum Hemorrhage and Associated Outcomes at a Midwest Academic Medical CenterMegan Mooberry, Natalie Voss, Linder Wendt, et al.
AIDS Research and Human Retroviruses|October 25, 2002
Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assaysSheila M Keating, Robert C Bollinger, Thomas C Quinn, et al.
Journal of Cutaneous Pathology|June 20, 2007
Langerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infectionJanis M Taube, Andrew D Nichols, Lynette S Bornman, et al.
Journal of Clinical Microbiology|June 9, 2004
Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral loadJ Brooks Jackson, Estelle Piwowar-Manning, LeTanya Johnson-Lewis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 27, 2005
Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012Susan H Eshleman, Laura A Guay, Anthony Mwatha, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|January 17, 2024
Tolerance for Ambiguity: Correlations With Medical and Physical Therapy Student Traits and Experiences Within the Learning EnvironmentShauna Dudley-Javoroski, Christopher S Cooper, J Brooks Jackson, et al.
AIDS (London, England)|February 25, 2003
A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high riskJ Brooks Jackson, Scott Barnett, Estelle Piwowar-Manning, et al.
Pageof 14